{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T17:31:19Z","timestamp":1770485479365,"version":"3.49.0"},"reference-count":27,"publisher":"BMJ","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1136\/bjophthalmol-2012-302130","type":"journal-article","created":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T03:35:14Z","timestamp":1354332914000},"page":"1118-1122","source":"Crossref","is-referenced-by-count":18,"title":["Ten-year experience of pulsed intravenous cyclophosphamide and methylprednisolone protocol (PICM protocol) in severe ocular inflammatory disease"],"prefix":"10.1136","volume":"97","author":[{"given":"Imran J","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J","family":"Barry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwesi N","family":"Amissah-Arthur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Carruthers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivasa Rao","family":"Elamanchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deva","family":"Situnayake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip I","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alastair K","family":"Denniston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saaeha","family":"Rauz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2012,11,30]]},"reference":[{"key":"key-10.1136\/bjophthalmol-2012-302130-1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000078612","article-title":"Uveitis: a potentially blinding disease","volume":"218","author":"Durrani","year":"2004","journal-title":"Ophthalmologica"},{"key":"key-10.1136\/bjophthalmol-2012-302130-2","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.rdc.2007.08.002","article-title":"Scleritis and peripheral ulcerative keratitis","volume":"33","author":"Galor","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"key":"key-10.1136\/bjophthalmol-2012-302130-3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2012-302130-4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3109\/09273940903072443","article-title":"Clinical review: anti-TNFalpha therapies in uveitis: perspective on 5\u2005years of clinical experience","volume":"17","author":"Sharma","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"key":"key-10.1136\/bjophthalmol-2012-302130-5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.autrev.2011.07.001","article-title":"Anti-CD 20 monoclonal antibody (rituximab) treatment for inflammatory ocular diseases","volume":"11","author":"Miserocchi","year":"2011","journal-title":"Autoimmun Rev"},{"key":"key-10.1136\/bjophthalmol-2012-302130-6","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0095-4543(03)00038-1","article-title":"Management of patients on chronic glucocorticoid therapy: an endocrine perspective","volume":"30","author":"Trence","year":"2003","journal-title":"Prim Care"},{"key":"key-10.1136\/bjophthalmol-2012-302130-7","first-page":"265","article-title":"Case of uveitis of unknown etiology treated with nitrogen mustards","volume":"41","author":"Roda","year":"1951","journal-title":"Rev Clin Esp"},{"key":"key-10.1136\/bjophthalmol-2012-302130-8","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.ophtha.2003.08.034","article-title":"Pulse IV cyclophosphamide in ocular inflammatory disease: efficacy and short-term safety","volume":"111","author":"Durrani","year":"2004","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2012-302130-9","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0190-9622(84)80193-0","article-title":"Cyclophosphamide (Cytoxan). A review on relevant pharmacology and clinical uses","volume":"11","author":"Ahmed","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"key-10.1136\/bjophthalmol-2012-302130-10","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial","volume":"150","author":"de Groot","year":"2009","journal-title":"Ann Intern Med"},{"key":"key-10.1136\/bjophthalmol-2012-302130-11","first-page":"295","article-title":"Pulse cyclophosphamide in the treatment of neuropsychiatric systemic lupus erythematosus","volume":"14","author":"Ramos","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"key-10.1136\/bjophthalmol-2012-302130-12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/qjmed\/90.6.401","article-title":"Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis","volume":"90","author":"Adu","year":"1997","journal-title":"QJM"},{"key":"key-10.1136\/bjophthalmol-2012-302130-13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7861\/clinmedicine.1-1-7","article-title":"Rational therapy in systemic necrotising vasculitis","volume":"1","author":"Carruthers","year":"2001","journal-title":"Clin Med"},{"key":"key-10.1136\/bjophthalmol-2012-302130-14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2012-302130-15","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ophtha.2010.08.027","article-title":"A standardized grading system for scleritis","volume":"118","author":"Sen","year":"2011","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2012-302130-16","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ophtha.2009.06.060","article-title":"Cyclophosphamide for ocular inflammatory diseases","volume":"117","author":"Pujari","year":"2010","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2012-302130-17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/09273940902818861","article-title":"International criteria for the diagnosis of ocular sarcoidosis: results of the first international workshop on ocular sarcoidosis (IWOS)","volume":"17","author":"Herbort","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"key":"key-10.1136\/bjophthalmol-2012-302130-18","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0161-6420(90)32485-5","article-title":"Scleritis in relapsing polychondritis. Response to therapy","volume":"97","author":"Hoang-Xaun","year":"1990","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2012-302130-19","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00003226-199507000-00010","article-title":"Destructive corneal and scleral disease associated with rheumatoid arthritis. Medical and surgical management","volume":"14","author":"Messmer","year":"1995","journal-title":"Cornea"},{"key":"key-10.1136\/bjophthalmol-2012-302130-20","first-page":"123","article-title":"Treatment of severe refractory uveitis with intravenous cyclophosphamide","volume":"21","author":"Rosenbaum","year":"1994","journal-title":"J Rheumatol"},{"key":"key-10.1136\/bjophthalmol-2012-302130-21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9394(84)90179-X","article-title":"Therapy of Mooren's ulcer","volume":"98","author":"Brown","year":"1984","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2012-302130-22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0021-8707(69)90148-8","article-title":"Cyclophosphamide therapy of Behcet's disease","volume":"43","author":"Buckley","year":"1969","journal-title":"J Allergy"},{"key":"key-10.1136\/bjophthalmol-2012-302130-23","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1001\/archopht.1969.00990010630006","article-title":"Immunosuppressive therapy of ocular inflammatory diseases","volume":"81","author":"Wong","year":"1969","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2012-302130-24","first-page":"569","article-title":"Pulse cyclophosphamide in Beh\u00e7et's disease","volume-title":"Beh\u00e7et's disease, basic and clinical aspects","author":"Fain","year":"1991"},{"key":"key-10.1136\/bjophthalmol-2012-302130-25","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/rheumatology\/kem146a","article-title":"BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis","volume":"46","author":"Lapraik","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"key-10.1136\/bjophthalmol-2012-302130-26","volume-title":"Rheumatoid arthritis: NICE guideline CG79","author":"National Institute for Health and Clinical Excellence","year":"2009"},{"key":"key-10.1136\/bjophthalmol-2012-302130-27","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/ard.2008.088096","article-title":"EULAR recommendations for the management of primary small and medium vessel vasculitis","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2012-302130","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:42:29Z","timestamp":1601109749000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2012-302130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,30]]},"references-count":27,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,8,9]]},"published-print":{"date-parts":[[2013,9]]}},"alternative-id":["10.1136\/bjophthalmol-2012-302130"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2012-302130","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,30]]}}}